Published in Inflamm Res on July 01, 2002
The central role of wear debris in periprosthetic osteolysis. HSS J (2006) 1.85
Orthopedic gene therapy in 2008. Mol Ther (2008) 0.98
The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Biomaterials (2009) 0.96
New animal models of wear-particle osteolysis. Int Orthop (2010) 0.92
Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. Gene Ther (2010) 0.90
High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model. Sarcoma (2007) 0.85
Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. Gene Ther (2012) 0.85
Circulating blood monocytes traffic to and participate in the periprosthetic tissue inflammation. Inflamm Res (2009) 0.84
Cytokine homologs of human gammaherpesviruses. J Interferon Cytokine Res (2011) 0.83
Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med (2014) 0.79
Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. ScientificWorldJournal (2013) 0.78
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature (2001) 6.62
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76
Structure and expression of the human gene encoding major heat shock protein HSP70. Mol Cell Biol (1985) 4.79
Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol (2000) 3.05
Distance determined by the angular declination below the horizon. Nature (2001) 2.90
Nitric oxide and arthritis. Arthritis Rheum (1993) 2.83
Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol (1998) 2.57
HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med (1980) 2.52
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol (2001) 2.33
Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology (1996) 2.25
The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol (1992) 2.21
Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. Antimicrob Agents Chemother (1996) 2.13
Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) (1996) 2.13
Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature (1991) 2.12
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07
The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study. Aliment Pharmacol Ther (2013) 2.02
Regulation of the human hsp70 promoter by p53. Science (1993) 2.02
Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther (2000) 2.01
CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene (1993) 1.95
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. J Med Chem (2000) 1.94
Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine (Phila Pa 1976) (1997) 1.94
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (1992) 1.93
STV1 gene encodes functional homologue of 95-kDa yeast vacuolar H(+)-ATPase subunit Vph1p. J Biol Chem (1994) 1.87
In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum (1997) 1.87
Creation and diagnosis of a solid-density plasma with an X-ray free-electron laser. Nature (2012) 1.74
Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance. J Int Med Res (2012) 1.71
Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A (1993) 1.65
B lymphocyte alloantigens in the study of the genetic basis of rheumatoid arthritis. Ann Rheum Dis (1977) 1.65
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res (1994) 1.64
Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA. Gene Ther (1995) 1.63
Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc Natl Acad Sci U S A (1991) 1.63
Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum (2009) 1.60
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol (2000) 1.60
Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer. Proc Natl Acad Sci U S A (1995) 1.56
Uncoupled expression of p33 and p92 permits amplification of tomato bushy stunt virus RNAs. J Virol (1998) 1.55
Incorporation of 5-substituted uracil derivatives into nucleic acids. II. Incorporation of 5-vinyluracil into the DNA of Escherichia coli. Biochim Biophys Acta (1973) 1.54
Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci U S A (1998) 1.54
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53
Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther (2002) 1.53
Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum (1984) 1.52
Expression of heat shock protein 70 is altered by age and diet at the level of transcription. Mol Cell Biol (1993) 1.52
A proapoptotic peptide for the treatment of solid tumors. Cancer Res (2001) 1.52
Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976) (1999) 1.51
The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations. Am J Sports Med (1998) 1.51
Cyclic tensile strain acts as an antagonist of IL-1 beta actions in chondrocytes. J Immunol (2000) 1.47
The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem (1995) 1.46
The utility of PRO data on surgical volume: the example of carotid endarterectomy. QRB Qual Rev Bull (1993) 1.43
Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med (1995) 1.42
Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem (2000) 1.42
Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases. Acta Orthop Scand (1999) 1.42
N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum (1994) 1.39
Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther (2000) 1.39
Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev (2006) 1.38
Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci U S A (1995) 1.37
Gene transfer to synoviocytes: prospects for gene treatment of arthritis. DNA Cell Biol (1992) 1.37
Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37
Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis (2008) 1.36
Cyclic tensile stress exerts antiinflammatory actions on chondrocytes by inhibiting inducible nitric oxide synthase. J Immunol (1999) 1.36
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem (2001) 1.36
Neoplastic transformation of guinea pig fetal cells in culture induced by chemical carcinogens. Cancer Res (1975) 1.35
TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med (2001) 1.34
Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol (1996) 1.33
Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol (1997) 1.32
Nanoscale spin reversal by non-local angular momentum transfer following ultrafast laser excitation in ferrimagnetic GdFeCo. Nat Mater (2013) 1.31
Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol (1997) 1.31
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther (1996) 1.31
SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene (1993) 1.31
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.29
Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol (1996) 1.29
trans Activation of the simian virus 40 enhancer. Mol Cell Biol (1986) 1.29
Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes (1999) 1.29
Nitric oxide in osteoarthritis. Osteoarthritis Cartilage (1999) 1.29
Osteoarthritis gene therapy. Gene Ther (2004) 1.28
IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol (1998) 1.28
Cloning of a Ca(2+)-ATPase gene and the role of cytosolic Ca2+ in the gibberellin-dependent signaling pathway in aleurone cells. Plant J (1997) 1.27
Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol (2001) 1.27
Collagen-induced arthritis in the mouse. Methods Enzymol (1988) 1.26
Coherence properties of individual femtosecond pulses of an x-ray free-electron laser. Phys Rev Lett (2011) 1.26
Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol (1995) 1.26
Evolutionary relationships between trematodes and snails emphasizing schistosomes and paragonimids. Parasitology (2001) 1.26
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol (1995) 1.25
Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol (1999) 1.24
Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther (2004) 1.24
Astrocytoma mimicking the features of pheochromocytoma. N Engl J Med (1972) 1.23
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol (1999) 1.22